Sveriges mest populära poddar
Emergency Medicine Cases
Hälsa och motionMedicin

EM Quick Hits 55 – Induction Agents, Gabapentinoids, Neuroprotective Intubation, Approach to Paresthesias, Preventing Burnout

58 min•27 februari 2024
Anand Swaminathan on an update on the appropriate selection of induction agents. Hans Rosenberg on when to use gabapentinoids for pain control in the ED. Katie Lin on pearls for neuroprotective intubation. Nour Khatib and Hamza Jalal on an approach to paresthesias in the ED. Eric Wortmann on preventing burnout in emergency medicine. Please support EM Cases with a donation https://emergencymedicinecases.com/donation/

Fler avsnitt av Emergency Medicine Cases

Visa alla avsnitt av Emergency Medicine Cases
Ep 215 Cardiac Arrest Update: Beyond the 2025 Guidelines Part 1: CPR, Defibrillation and Ventilation
•1 tim 53 min
EM Quick Hits 71 EMC²: Fever Without a Source, Coaching the EM Mind Part 1, Traumatic Pneumothorax Part 2, PECARN C-spine Rule, Medetomidine Withdrawal, EMS Handover
•1 tim 39 min
Ep 214 Bridging the Gap in Endometriosis Care: Recognition, Risk Stratification, and ED-Initiated Management
•56 min
Ep 213 Update in Management of Status Epilepticus
•59 min
Ep 212 PECARN Febrile Young Infant Prediction Tool: When To Safely Forgo LP and Empiric Antibiotics
•48 min
EM Quick Hits 70 MedMal Cases Upper Back Pain, Traumatic Pneumothorax/Hemothorax Decision Making, Risk Stratification of ICH for Consultation, Post-Circumcision Bleeds, IV Contrast Allergy, Emotional Contagion
•1 tim 6 min
Ep 211 Thyrotoxicosis and Thyroid Storm: Recognition and Management
•1 tim 13 min
Ep 210 Decompensated Hypothyroidism Recognition and Management
•1 tim 12 min
EM Quick Hits 69 Pediatric Urinary Retention & Acute Transverse Myelitis, Post-Dural Puncture Headache, Med Mal Cases: Clenched Fist Injury, IV Thrombolysis for Minor Stroke, EM Leadership Spotlight #4
•1 tim 32 min
Ep 209 Nondisabling Stroke Recognition and Management
•1 tim 20 min

Emergency Medicine Cases med Dr. Anton Helman finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.